Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MYRIAD GENETICS INC Director's Dealing 2024

Jan 29, 2024

32566_dirs_2024-01-29_3a2c1038-5d29-4a8f-b8a9-76e83f625bec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2024-01-29

Reporting Person: Leffler Scott J. (Chief Financial Officer)

More from MYRIAD GENETICS INC

Declaration of Voting Results & Voting Rights Announcements 2026
Jun 4
Regulatory Filings 2026
Jun 4
Share Issue/Capital Change 2026
Jun 4
Interim / Quarterly Report 2026
May 6
Report Publication Announcement 2026
May 5
Annual Report 2026
Apr 14
Proxy Solicitation & Information Statement 2026
Apr 14
Proxy Solicitation & Information Statement 2026
Apr 14
Major Shareholding Notification 2026
Apr 7
Major Shareholding Notification 2026
Mar 27
View all filings →